Aase syndrome
A rare genetic disorder characterized by anemia and skeletal abnormalities
Overview

Aase syndrome is a rare genetic disorder that is primarily characterized by anemia and various skeletal abnormalities. It is typically inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder.
Clinical Features
Individuals with Aase syndrome often present with a range of clinical features, which may include:
- Anemia: A reduction in the number of red blood cells, leading to symptoms such as fatigue, pallor, and shortness of breath.
- Skeletal abnormalities: These may include triphalangeal thumb, hypoplastic thumb, and other limb anomalies.
- Growth retardation: Affected individuals may experience delayed growth and development.
- Craniofacial anomalies: Such as a cleft palate or a high-arched palate.
Pathophysiology
The exact pathophysiology of Aase syndrome is not fully understood. However, it is believed to involve defects in ribosome biogenesis, which affects the production of red blood cells and leads to the hematological and skeletal manifestations of the disorder.
Diagnosis
Diagnosis of Aase syndrome is based on clinical evaluation, family history, and laboratory tests. A complete blood count (CBC) may reveal macrocytic anemia. Genetic testing can confirm the diagnosis by identifying mutations in genes associated with the syndrome.
Management
Management of Aase syndrome is symptomatic and supportive. Treatment may include:
- Blood transfusions: To manage severe anemia.
- Growth hormone therapy: To address growth retardation.
- Surgical intervention: For correction of skeletal abnormalities or craniofacial anomalies.
Prognosis
The prognosis for individuals with Aase syndrome varies depending on the severity of the symptoms. With appropriate management, many individuals can lead relatively normal lives, although they may require ongoing medical care.
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian